Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 2	2026-09-03		NCT07356973

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
CRISM Therapeutics LTD	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Hospitals Birmingham NHS Foundation Trust	Birmingham	United Kingdom	14

Clinical trials